An initiative by Medtalks, in association with Mankind Pharma to bring to you new findings from key trials, in the prevention and management of diabetes.
In this Issue 2 we will discuss about NAFLD and SGLT2 inhibitors. NAFLD is closely linked with type 2 diabetes. The role of SGLT2 inhibitors; Justification; Current trials status; Future of SGLT2i in NAFLD; Currently available drugs for NAFLD. A recent research has shown that patients with NAFLD have a higher risk of diabetes, and the more severe the disease the greater the risk.